2:33 PM
Mar 13, 2018
 |  BC Extra  |  Company News

Management tracks: Ipsen, Illumina

Ipsen Group (Euronext:IPN; Pink:IPSEY) hired Ivana Magovcevic-Liebisch as EVP and CBO. She was EVP and chief strategy and corporate development officer at Axcella Health Inc. (Cambridge, Mass.).

Genomics company Illumina Inc. (NASDAQ:ILMN) hired Phil Febbo as CMO, effective March 26. He is CMO at Genomic Health Inc. (NASDAQ:GHDX).

Cancer company Ideaya Biosciences Inc. (South San Francisco, Calif.) hired Julie Hambleton as SVP and CMO, head of development. She was VP and head of U.S. medical at Bristol-Myers Squibb Co. (NYSE:BMY).

Renal company Goldfinch Biopharma Inc. (Cambridge, Mass.) said Founder Peter Mundel will transition to CSO. He was SVP of biology.

Rare genetic disease company Therachon AG (Basel, Switzerland) hired Aled Williams as chief commercial officer and head of patient access. He was VP and global strategy head for rare gastrointestinal diseases at Shire plc (LSE:SHP; NASDAQ:SHPG).

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD